TreeWAS – Variant ID: rs17382723

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z50.8 Care involving use of rehabilitation procedures	0.037	0.963	0.000
K74.6 Other and unspecified cirrhosis of liver	0.021	0.979	0.000
D25.9 Leiomyoma of uterus, unspecified	0.000	0.979	0.021
K74 Fibrosis and cirrhosis of liver	0.012	0.987	0.000
K74.0 Hepatic fibrosis	0.011	0.989	0.000
K70-K77 Diseases of liver	0.010	0.990	0.000
K73 Chronic hepatitis, not elsewhere classified	0.010	0.990	0.000
K73.9 Chronic hepatitis, unspecified	0.009	0.991	0.000
K74.4 Secondary biliary cirrhosis	0.009	0.991	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.009	0.991	0.000
K74.1 Hepatic sclerosis	0.009	0.991	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.991	0.009
K75.4 Autoimmune hepatitis	0.008	0.992	0.000
K75 Other inflammatory liver diseases	0.008	0.992	0.000
K71 Toxic liver disease	0.008	0.992	0.000
K72 Hepatic failure, not elsewhere classified	0.008	0.992	0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.008	0.992	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.008	0.992	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.008	0.992	0.000
K77 Liver disorders in diseases classified elsewhere	0.007	0.993	0.000
K72.9 Hepatic failure, unspecified	0.007	0.993	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.007	0.993	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.007	0.993	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.007	0.993	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.007	0.993	0.000
K76.6 Portal hypertension	0.007	0.993	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.007	0.993	0.000
K74.5 Biliary cirrhosis, unspecified	0.006	0.993	0.000
K76 Other diseases of liver	0.007	0.993	0.000
K72.1 Chronic hepatic failure	0.006	0.993	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.006	0.993	0.000
H50.9 Strabismus, unspecified	0.000	0.994	0.006
H81.0 Meniere's disease	0.006	0.994	0.000
K75.2 Nonspecific reactive hepatitis	0.006	0.994	0.000
K75.1 Phlebitis of portal vein	0.006	0.994	0.000
K71.9 Toxic liver disease, unspecified	0.006	0.994	0.000
K71.8 Toxic liver disease with other disorders of liver	0.006	0.994	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.006	0.994	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.006	0.994	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.006	0.994	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.006	0.994	0.000
K71.2 Toxic liver disease with acute hepatitis	0.006	0.994	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.006	0.994	0.000
K71.0 Toxic liver disease with cholestasis	0.006	0.994	0.000
D41.4 Bladder	0.006	0.994	0.000
H52.1 Myopia	0.006	0.994	0.000
K75.9 Inflammatory liver disease, unspecified	0.006	0.994	0.000
K75.8 Other specified inflammatory liver diseases	0.005	0.994	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.005	0.994	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.005	0.994	0.000
K76.1 Chronic passive congestion of liver	0.005	0.995	0.000
K70 Alcoholic liver disease	0.005	0.995	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.995	0.005
K76.5 Hepatic veno-occlusive disease	0.005	0.995	0.000
K76.4 Peliosis hepatis	0.005	0.995	0.000
K76.3 Infarction of liver	0.005	0.995	0.000
K76.2 Central haemorrhagic necrosis of liver	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
K76.8 Other specified diseases of liver	0.005	0.995	0.000
Z48.0 Attention to surgical dressings and sutures	0.005	0.995	0.000
R82.9 Other and unspecified abnormal finding in urine	0.005	0.995	0.000
D25 Leiomyoma of uterus	0.000	0.995	0.005
K72.0 Acute and subacute hepatic failure	0.004	0.995	0.000
R06.0 Dyspnoea	0.004	0.996	0.000
K70.1 Alcoholic hepatitis	0.004	0.996	0.000
H81 Disorders of vestibular function	0.004	0.996	0.000
K70.9 Alcoholic liver disease, unspecified	0.004	0.996	0.000
K76.9 Liver disease, unspecified	0.004	0.996	0.000
R57.2 Septic shock	0.004	0.996	0.000
S49.9 Unspecified injury of shoulder and upper arm	0.004	0.996	0.000
I85.9 Oesophageal varices without bleeding	0.004	0.996	0.000
K74.3 Primary biliary cirrhosis	0.004	0.996	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.004	0.996	0.000
K70.0 Alcoholic fatty liver	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
E21.3 Hyperparathyroidism, unspecified	0.000	0.996	0.004
H83.0 Labyrinthitis	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y45.1 Salicylates	0.004	0.996	0.000
D86.0 Sarcoidosis of lung	0.000	0.996	0.004
H52.3 Anisometropia and aniseikonia	0.004	0.996	0.000
K26.7 Chronic without haemorrhage or perforation	0.000	0.996	0.004
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.004	0.996	0.000
H52 Disorders of refraction and accommodation	0.004	0.996	0.000
L72.0 Epidermal cyst	0.004	0.996	0.000
K85.9 Acute pancreatitis, unspecified	0.004	0.996	0.000
U89.8 Agent resistant to other single specified antibiotic	0.000	0.996	0.003
D25.2 Subserosal leiomyoma of uterus	0.000	0.997	0.003
H52.0 Hypermetropia	0.003	0.997	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.997	0.003
S46.0 Injury of tendon of the rotator cuff of shoulder	0.003	0.997	0.000
K76.7 Hepatorenal syndrome	0.003	0.997	0.000
S46.8 Injury of other muscles and tendons at shoulder and upper arm level	0.003	0.997	0.000
H83 Other diseases of inner ear	0.003	0.997	0.000
S46 Injury of muscle and tendon at shoulder and upper arm level	0.003	0.997	0.000
H81.9 Disorder of vestibular function, unspecified	0.003	0.997	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.003	0.997	0.000
H81.4 Vertigo of central origin	0.003	0.997	0.000
K75.0 Abscess of liver	0.003	0.997	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.003	0.997	0.000
H81.2 Vestibular neuronitis	0.003	0.997	0.000
H81.1 Benign paroxysmal vertigo	0.003	0.997	0.000
H81.8 Other disorders of vestibular function	0.003	0.997	0.000
R82 Other abnormal findings in urine	0.003	0.997	0.000
S46.3 Injury of muscle and tendon of triceps	0.003	0.997	0.000
Y85.0 Sequelae of motor-vehicle accident	0.003	0.997	0.000
H80-H83 Diseases of inner ear	0.003	0.997	0.000
Z48.8 Other specified surgical follow-up care	0.003	0.997	0.000
H81.3 Other peripheral vertigo	0.003	0.997	0.000
R06.1 Stridor	0.003	0.997	0.000
S46.1 Injury of muscle and tendon of long head of biceps	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
J02.9 Acute pharyngitis, unspecified	0.003	0.997	0.000
H52.6 Other disorders of refraction	0.003	0.997	0.000
H52.5 Disorders of accommodation	0.003	0.997	0.000
H52.4 Presbyopia	0.003	0.997	0.000
H83.8 Other specified diseases of inner ear	0.003	0.997	0.000
D41.1 Renal pelvis	0.003	0.997	0.000
R82.4 Acetonuria	0.003	0.997	0.000
L60.9 Nail disorder, unspecified	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
Z48 Other surgical follow-up care	0.003	0.997	0.000
D25.1 Intramural leiomyoma of uterus	0.000	0.997	0.003
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.997	0.003
R82.8 Abnormal findings on cytological and histological examination of urine	0.003	0.997	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.003	0.997	0.000
S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level	0.003	0.997	0.000
D86 Sarcoidosis	0.000	0.997	0.003
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.997	0.003
D89.3 Immune reconstitution syndrome	0.000	0.997	0.003
D89.1 Cryoglobulinaemia	0.000	0.997	0.003
L60.0 Ingrowing nail	0.003	0.997	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
H83.3 Noise effects on inner ear	0.003	0.997	0.000
H83.2 Labyrinthine dysfunction	0.003	0.997	0.000
H83.1 Labyrinthine fistula	0.003	0.997	0.000
R06.6 Hiccough	0.003	0.997	0.000
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level	0.003	0.997	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
C44.0 Skin of lip	0.000	0.997	0.003
D25.0 Submucous leiomyoma of uterus	0.000	0.997	0.003
D41.9 Urinary organ, unspecified	0.003	0.997	0.000
D41.7 Other urinary organs	0.003	0.997	0.000
D41.3 Urethra	0.003	0.997	0.000
K70.4 Alcoholic hepatic failure	0.002	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
D26.1 Corpus uteri	0.003	0.997	0.000
H52.7 Disorder of refraction, unspecified	0.002	0.997	0.000
I85.0 Oesophageal varices with bleeding	0.003	0.997	0.000
U89 Agent resistant to other and unspecified antibiotics	0.000	0.997	0.003
O36.9 Maternal care for foetal problem, unspecified	0.003	0.997	0.000
D48.0 Bone and articular cartilage	0.003	0.997	0.000
I85 Oesophageal varices	0.003	0.997	0.000
R06 Abnormalities of breathing	0.003	0.997	0.000
S49 Other and unspecified injuries of shoulder and upper arm	0.003	0.997	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.997	0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.002	0.997	0.000
Y41.5 Antiviral drugs	0.002	0.997	0.000
D41.0 Kidney	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.002	0.997	0.000
R82.3 Haemoglobinuria	0.002	0.997	0.000
R82.2 Biliuria	0.002	0.997	0.000
R82.1 Myoglobinuria	0.002	0.997	0.000
R82.0 Chyluria	0.002	0.997	0.000
L60 Nail disorders	0.003	0.997	0.000
R06.4 Hyperventilation	0.003	0.997	0.000
Y41.0 Sulphonamides	0.002	0.997	0.000
Y44.2 Anticoagulants	0.002	0.997	0.000
D41.2 Ureter	0.002	0.997	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.002	0.998	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.998	0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.002	0.998	0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.002	0.998	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.002	0.998	0.000
Y85 Sequelae of transport accidents	0.002	0.998	0.000
M79.54 Residual foreign body in soft tissue (Hand)	0.000	0.998	0.002
H61.8 Other specified disorders of external ear	0.000	0.998	0.002
H83.9 Disease of inner ear, unspecified	0.002	0.998	0.000
L60.8 Other nail disorders	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.002	0.998	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.002	0.998	0.000
D86.3 Sarcoidosis of skin	0.000	0.998	0.002
D48.7 Other specified sites	0.002	0.998	0.000
O36.5 Maternal care for poor foetal growth	0.002	0.998	0.000
V23.4 Driver injured in traffic accident	0.002	0.998	0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.002	0.998	0.000
L60.1 Onycholysis	0.002	0.998	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
K70.3 Alcoholic cirrhosis of liver	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
U89.9 Agent resistant to unspecified antibiotic	0.000	0.998	0.002
D86.8 Sarcoidosis of other and combined sites	0.000	0.998	0.002
Z88.0 Personal history of allergy to penicillin	0.000	0.998	0.002
R06.7 Sneezing	0.002	0.998	0.000
R06.3 Periodic breathing	0.002	0.998	0.000
S49.8 Other specified injuries of shoulder and upper arm	0.002	0.998	0.000
S49.7 Multiple injuries of shoulder and upper arm	0.002	0.998	0.000
V09 Pedestrian injured in other and unspecified transport accidents	0.002	0.998	0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
H80 Otosclerosis	0.002	0.998	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.998	0.002
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.998	0.002
I74.5 Embolism and thrombosis of iliac artery	0.000	0.998	0.002
L60.5 Yellow nail syndrome	0.002	0.998	0.000
L60.4 Beau's lines	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.998	0.002
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.002	0.998	0.000
I49.8 Other specified cardiac arrhythmias	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
D48.6 Breast	0.002	0.998	0.000
D48.1 Connective and other soft tissue	0.002	0.998	0.000
V09.1 Pedestrian injured in unspecified nontraffic accident	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
V20-V29 Motorcycle rider injured in transport accident	0.002	0.998	0.000
O36.8 Maternal care for other specified foetal problems	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.998	0.002
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.002	0.998	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.002	0.998	0.000
V09.2 Pedestrian injured in traffic accident involving other and unspecified motor vehicles	0.002	0.998	0.000
A49.8 Other bacterial infections of unspecified site	0.000	0.998	0.002
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.002	0.998	0.000
L60.3 Nail dystrophy	0.002	0.998	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.998	0.000
H49.0 Third [oculomotor] nerve palsy	0.000	0.998	0.002
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
D48.4 Peritoneum	0.002	0.998	0.000
D48.3 Retroperitoneum	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
V09.9 Pedestrian injured in unspecified transport accident	0.002	0.998	0.000
O36 Maternal care for other known or suspected foetal problems	0.002	0.998	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.002	0.998	0.000
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.998	0.002
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
O36.3 Maternal care for signs of foetal hypoxia	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
K92.1 Melaena	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
K85 Acute pancreatitis	0.002	0.998	0.000
E06.3 Autoimmune thyroiditis	0.000	0.998	0.002
L03.2 Cellulitis of face	0.002	0.998	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.002	0.998	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
L12.0 Bullous pemphigoid	0.002	0.998	0.000
V48.4 Person injured while boarding or alighting	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
Y00-Y09 Assault	0.002	0.998	0.000
D26.9 Uterus, unspecified	0.002	0.998	0.000
K85.3 Drug-induced acute pancreatitis	0.002	0.998	0.000
R06.2 Wheezing	0.002	0.998	0.000
R94.3 Abnormal results of cardiovascular function studies	0.000	0.998	0.002
W94.8 Other specified place	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.998	0.000
V24 Motorcycle rider injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
B02.3 Zoster ocular disease	0.002	0.998	0.000
H80.8 Other otosclerosis	0.002	0.998	0.000
H80.2 Cochlear otosclerosis	0.002	0.998	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.002	0.998	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.002	0.998	0.000
L12.9 Pemphigoid, unspecified	0.002	0.998	0.000
V09.3 Pedestrian injured in unspecified traffic accident	0.002	0.998	0.000
V09.0 Pedestrian injured in nontraffic accident involving other and unspecified motor vehicles	0.002	0.998	0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.002	0.998	0.000
V23.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
V23.5 Passenger injured in traffic accident	0.002	0.998	0.000
V23.3 Person injured while boarding or alighting	0.002	0.998	0.000
V23.2 Unspecified motorcycle rider injured in nontraffic accident	0.002	0.998	0.000
V23.1 Passenger injured in nontraffic accident	0.002	0.998	0.000
V23.0 Driver injured in nontraffic accident	0.002	0.998	0.000
X23.0 Home	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
H50 Other strabismus	0.000	0.998	0.002
V04 Pedestrian injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
V29 Motorcycle rider injured in other and unspecified transport accidents	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.000	0.998	0.002
Y00 Assault by blunt object	0.002	0.998	0.000
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.002	0.998	0.000
L60.2 Onychogryphosis	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
D83 Common variable immunodeficiency	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
L12 Pemphigoid	0.002	0.998	0.000
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.002	0.998	0.000
W94 Exposure to high and low air pressure and changes in air pressure	0.002	0.998	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.002	0.998	0.000
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
D48.5 Skin	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.002	0.998	0.000
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
I22.9 Subsequent myocardial infarction of unspecified site	0.002	0.998	0.000
L12.1 Cicatricial pemphigoid	0.002	0.998	0.000
V26 Motorcycle rider injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V25 Motorcycle rider injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V21 Motorcycle rider injured in collision with pedal cycle	0.002	0.998	0.000
V20 Motorcycle rider injured in collision with pedestrian or animal	0.002	0.998	0.000
X59.2 School, other institution and public administrative area	0.002	0.998	0.000
Y53.4 Other laxatives	0.001	0.998	0.000
Z48.9 Surgical follow-up care, unspecified	0.002	0.998	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.998	0.002
U83 Resistance to other antibiotics	0.000	0.998	0.002
U82 Resistance to betalactam antibiotics	0.000	0.998	0.002
U85 Resistance to antineoplastic drugs	0.000	0.998	0.002
V22 Motorcycle rider injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V48 Car occupant injured in noncollision transport accident	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
H50.4 Other and unspecified heterotropia	0.000	0.998	0.002
V04.1 Traffic accident	0.002	0.998	0.000
V28.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
Y00.0 Home	0.002	0.998	0.000
Y87.1 Sequelae of assault	0.002	0.998	0.000
Z71.6 Tobacco abuse counselling	0.002	0.998	0.000
V06 Pedestrian injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V05 Pedestrian injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V03 Pedestrian injured in collision with car, pick-up truck or van	0.002	0.998	0.000
V02 Pedestrian injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V27 Motorcycle rider injured in collision with fixed or stationary object	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
H90.2 Conductive hearing loss, unspecified	0.002	0.998	0.000
K85.2 Alcohol-induced acute pancreatitis	0.002	0.998	0.000
Y04 Assault by bodily force	0.002	0.998	0.000
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
K85.8 Other acute pancreatitis	0.002	0.998	0.000
V24.4 Driver injured in traffic accident	0.001	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
V98-V99 Other and unspecified transport accidents	0.002	0.998	0.000
H44.2 Degenerative myopia	0.002	0.998	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.002	0.998	0.000
O36.2 Maternal care for hydrops foetalis	0.002	0.998	0.000
O36.1 Maternal care for other isoimmunisation	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.001	0.998	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.998	0.002
V01 Pedestrian injured in collision with pedal cycle	0.001	0.998	0.000
Y10-Y34 Event of undetermined intent	0.002	0.998	0.000
X20-X29 Contact with venomous animals and plants	0.002	0.998	0.000
O36.4 Maternal care for intra-uterine death	0.002	0.998	0.000
V29.3 Motorcycle rider [any] injured in unspecified nontraffic accident	0.001	0.998	0.000
Y40.4 Tetracyclines	0.001	0.998	0.000
Y40.2 Chloramphenicol group	0.001	0.998	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.002	0.998	0.000
V40-V49 Car occupant injured in transport accident	0.002	0.998	0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.001	0.998	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.002	0.998	0.000
H61.1 Non-infective disorders of pinna	0.000	0.998	0.002
N75.1 Abscess of Bartholin's gland	0.000	0.998	0.002
Y00.9 Unspecified place	0.001	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.998	0.000
Y65.8 Other specified misadventures during surgical and medical care	0.002	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.998	0.001
V99 Unspecified transport accident	0.002	0.998	0.000
Y09 Assault by unspecified means	0.001	0.998	0.000
V95-V97 Air and space transport accidents	0.002	0.998	0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.001	0.998	0.000
E13.9 Without complications	0.000	0.998	0.002
W49.0 Home	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.001	0.998	0.000
Y47.1 Benzodiazepines	0.001	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.998	0.000
Y73.2 Prosthetic and other implants, materials and accessory devices	0.001	0.998	0.000
J02 Acute pharyngitis	0.002	0.998	0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
K85.0 Idiopathic acute pancreatitis	0.001	0.998	0.000
V24.9 Unspecified motorcycle rider injured in traffic accident	0.001	0.998	0.000
V24.5 Passenger injured in traffic accident	0.001	0.998	0.000
V24.3 Person injured while boarding or alighting	0.001	0.998	0.000
V24.2 Unspecified motorcycle rider injured in nontraffic accident	0.001	0.998	0.000
V24.1 Passenger injured in nontraffic accident	0.001	0.998	0.000
V24.0 Driver injured in nontraffic accident	0.001	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
Y42.4 Oral contraceptives	0.001	0.998	0.000
Y42.2 Antithyroid drugs	0.001	0.998	0.000
Y08 Assault by other specified means	0.001	0.998	0.000
Y07 Other maltreatment syndromes	0.001	0.998	0.000
Y06 Neglect and abandonment	0.001	0.998	0.000
Y05 Sexual assault by bodily force	0.001	0.998	0.000
Y03 Assault by crashing of motor vehicle	0.001	0.998	0.000
Y02 Assault by pushing or placing victim before moving object	0.001	0.998	0.000
Y01 Assault by pushing from high place	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations